Henry Schein partners with Cerebral Assessment Systems: 5 things to know

Mackenzie Garrity -   Print  |

Henry Schein partnered with Cerebral Assessment Systems to distribute Cognivue, a computerized assessment screening device to detect early signs of dementia.

Here are five things to know:


1. Cognivue is designed to help physicians monitor current brain health and identify future reversible dementia treatment options.


2. The device displays controlled visual stimuli on a computer screen, allowing physicians to conduct quantitative analysis of brain health.


3. Cognivue then summarizes the results into a single quantitative brain health score, enabling physicians to identify potential issues.


4. Cognivue monitors and measures how the brain processes information. The test is customized based on the individual patient, calibrating levels of difficulty based on how well a patient's brain is performing.


5. Charles Duffy, MD, created Cognivue based on years of neurophysiological and psychophysical research.


More articles on imaging:
Global C-arm market to exceed $3.46B by 2022: 4 takeaways
JointPoint signs exclusive agreement with DePuy Synthes: 6 things to know
NuVasive launches LessRay technology to reduce radiation exposure: 5 key notes

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers